Priveterra Acquisition Corp. [Rocket]

Date Filed

Type

Description

10/02/2023

8-K

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data

08/22/2023

SC 13D/A

Strathspey Crown Holdings, LLC reports a 5.5% stake in AEON Biopharma, Inc.

08/22/2023

DEL AM

Form DEL AM - Delaying amendment:

08/18/2023

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933:

08/16/2023

4

Thunen Shelley B (Director) has filed a Form 4 on AEON Biopharma, Inc.

Txns:

Granted 58,851 options @ $5.47, valued at $321.9k

08/16/2023

4

PALMISANO ROBERT J (10% Owner) has filed a Form 4 on AEON Biopharma, Inc.

Txns:

Granted 58,851 options @ $5.47, valued at $321.9k

08/16/2023

4

FISCHER JOST (Director) has filed a Form 4 on AEON Biopharma, Inc.

Txns:

Granted 58,851 options @ $5.47, valued at $321.9k

08/16/2023

4

Carter Eric G (Director) has filed a Form 4 on AEON Biopharma, Inc.

Txns:

Granted 58,851 options @ $5.47, valued at $321.9k

08/14/2023

4

Strathspey Crown Holdings Group, LLC (10% Owner) has filed a Form 4 on AEON Biopharma, Inc.

Txns:

Sold 7,380,394 shares @ $10, valued at $73.8M

07/31/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/31/2023

SC 13D

Form SC 13D - General statement of acquisition of beneficial ownership:

07/31/2023

SC 13G

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

07/28/2023

SC 13D

Daewoong Co., Ltd reports a 24% stake in AEON Biopharma, Inc.

07/28/2023

3

Daewoong Co., Ltd (10% Owner) has filed a Form 3 on AEON Biopharma, Inc.

07/27/2023

8-K

Director compensation was amended/approved, Entered into an underwriting agreement for the issuance and sale of notes

Docs:

"THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRIVETERRA ACQUISITION CORP. Priveterra Acquisition Corp. , a corporation organized and existing under the General Corporation Law of the State of Delaware , does hereby certify as follows: 1.            The name of the Corporation is Priveterra Acquisition Corp. The Corporation was incorporated under the name Priveterra Acquisition Corp. by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on November 17, 2020 and is being amended and restated to reflect that the Corporation has changed its name. 2.             An amended and resta...",
"AEON Biopharma, Inc. as of July 21, 2023",
"AEON BIOPHARMA, INC. AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN Effective July 21, 2023 AEON BIOPHARMA, INC. AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN 1.             Purposes of the Plan . The purposes of this AEON Biopharma, Inc. Amended and Restated 2019 Incentive Award Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company’ s business. Options granted under the Plan may be Incentive Stock Options or Non-Qualified Stock Options, as determined by the Administrator at the time of grant. Stock Appreciation Rights, Stock Purchase Rights, Restri...",
"2 subject thereto upon the date of Optionee’s termination. II. AGREEMENT 1. Grant of Option. The Company hereby grants to Optionee an Option to purchase the number of Shares set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant . Notwithstanding anything to the contrary anywhere else in this Stock Option Agreement, the Option is subject to the terms, definitions and provisions of the Plan adopted by the Company, which is incorporated herein by reference. If designated in the Notice of Grant as an Incentive Stock Option, the Option is intended to qualify as an incentive stock option as defined in Section 422 of the Code; provided, however, that to the extent that the aggregate Fair Market Value of stock with respect to which incentive stock optio...",
"US-DOCS\140721846.3 EXHIBIT A RESTRICTED STOCK UNIT AGREEMENT Capitalized terms not specifically defined in this Restricted Stock Unit Agreement have the meanings specified in the Grant Notice or, if not defined in the Grant Notice, in the Plan. ARTICLE I. GENERAL 1.1 Award of RSUs. The Company has granted the RSUs to Participant effective as of the Grant Date set forth in the Grant Notice . Each RSU represents the right to receive one Share as set forth in this Agreement. Participant will have no right to the distribution of any Shares until the time the RSUs have vested. 1.2 Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan...",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"2 US-DOCS\137441470.5 Restructuring) paid by the Participant for such Shares or not issuing any Shares covered by the Award or Prior Plan Award, the unused Shares covered by the Award or Prior Plan Award will, as applicable, become or again be available for Award grants under the Plan. Further, Shares delivered to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award or Prior Plan Award and/or to satisfy any applicable tax withholding obligation with respect to an Award or Prior Plan Award will, as applicable, become or again be available for Award grants under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards or Prior Plan Awards shall not count against the Overall Share Limit. Notwithstanding anything ...",
"2 US-DOCS\138377375.2 c. Payment of Retainers. The annual cash retainers described in Sections 1 and 1 shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears not later than 30 days following the end of each calendar quarter. In the event an Eligible Director does not serve as a director, or in the applicable positions described in Section 1, for an entire calendar quarter, the retainer paid to such Eligible Director shall be prorated for the portion of such calendar quarter actually served as a director, or in such position, as applicable. 2. Equity Compensation. a. General. Eligible Directors shall be granted the equity awards described below. The awards described below shall be granted under and shall be subject to the terms and provi...",
"EXHIBI 10.11",
"EMPLOYMENT AGREEMENT"

07/26/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

4

Form 4 - Statement of changes in beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

3

Form 3 - Initial statement of beneficial ownership of securities:

07/24/2023

8-K

Quarterly results

07/21/2023

CERT

Form CERT - Certification by an exchange approving securities for listing:

07/21/2023

25

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:

07/21/2023

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]:

07/21/2023

10-Q

Quarterly Report for the period ended June 30, 2023

07/20/2023

SC 13G/A

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Next >>